Literature DB >> 8160767

In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.

G J Nuovo1, F Gallery, P MacConnell, A Braun.   

Abstract

This study determined the distribution of in situ polymerase chain reaction (PCR)-amplified HIV-1 nucleic acids in the central nervous system (CNS). Amplified viral DNA was detected in each of the seven HIV-1-positive cases and in none of the seven negative controls. HIV-1 DNA was rarely detected with standard in situ hybridization, consistent with low levels of proviral DNA. In patients with minimal clinical and pathological CNS involvement, only rare HIV-1 DNA-positive perivascular microglial cells were noted. In patients with dementia, many infected neurons and astrocytes as well as microglial cells were detected. Severe disease was also characterized by the detection of tumor necrosis factor-alpha (TNF-alpha) mRNA and viral RNA by reverse transcription (RT) in situ PCR. These results suggest that HIV-1 commonly exists in the CNS in the asymptomatic patient and that progression is marked by a dramatic increase of the number of cells with HIV-1 DNA, including neurons and astrocytes, and a concomitant upregulation of both viral and TNF-alpha transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160767      PMCID: PMC1887241     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

Review 1.  HIV-related neurotoxicity.

Authors:  S A Lipton
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

2.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

Authors:  R J Pomerantz; D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Specific tropism of HIV-1 for microglial cells in primary human brain cultures.

Authors:  B A Watkins; H H Dorn; W B Kelly; R C Armstrong; B J Potts; F Michaels; C V Kufta; M Dubois-Dalcq
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

4.  Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.

Authors:  C A Wiley; R D Schrier; J A Nelson; P W Lampert; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease.

Authors:  B Weiser; N Peress; D La Neve; D J Eilbott; R Seidman; H Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes.

Authors:  M Yamada; A Zurbriggen; M B Oldstone; R S Fujinami
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS).

Authors:  H Budka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 9.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

10.  Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

Authors:  J M Harouse; S Bhat; S L Spitalnik; M Laughlin; K Stefano; D H Silberberg; F Gonzalez-Scarano
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

View more
  75 in total

1.  CD4/CXCR4-independent infection of human astrocytes by a T-tropic strain of HIV-1.

Authors:  B Schweighardt; J T Shieh; W J Atwood
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

Review 2.  Virus receptors in the human central nervous system.

Authors:  B Schweighardt; W J Atwood
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

Review 3.  Chemokine receptors and neural function.

Authors:  Charlene Cho; Richard J Miller
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

4.  Colocalisation of human immunodeficiency virus and human cytomegalovirus infection in brain autopsy tissue from AIDS patients.

Authors:  I M Balluz; M A Farrell; E Kay; M J Staunton; J N Keating; O Sheils; S L Cosby; M J Mabruk; B J Sheahan; G J Atkins
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

Review 5.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

6.  Localization of herpes simplex virus type 1 DNA in latently infected BALB/c mice neurons using in situ polymerase chain reaction.

Authors:  Behzad Khansarinejad; Hoorieh Soleimanjahi; Amir Ghaemi; Taki Tiraihi; Shahram Pour Beiranvand
Journal:  Iran Biomed J       Date:  2010-07

7.  Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells.

Authors:  C Schwartz; P Catez; O Rohr; D Lecestre; D Aunis; E Schaeffer
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons.

Authors:  E Lavi; J M Strizki; A M Ulrich; W Zhang; L Fu; Q Wang; M O'Connor; J A Hoxie; F González-Scarano
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

9.  Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice.

Authors:  Elona Rrapo; Yuyan Zhu; Jun Tian; Huayan Hou; Adam Smith; Francisco Fernandez; Jun Tan; Brian Giunta
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

10.  Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro.

Authors:  Fatiha Radja; Denis G Kay; Steffen Albrecht; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.